No abstract available.
Humans ; Hypertension* ; Kidney Failure, Chronic* ; Renal Insufficiency*

No abstract available.
Humans ; Hypertension* ; Kidney Failure, Chronic* ; Renal Insufficiency*

No abstract available.
Child* ; Humans ; Kidney Failure, Chronic* ; Renal Insufficiency*

Humans ; Kidney Failure, Chronic ; therapy ; Renal Insufficiency, Chronic ; therapy

Diabetic nephropathy, the leading cause of chronic kidney disease, is a common and morbid complication of diabetes. Individuals with nephropathy are at a much greater risk for other micro- and macrovascular complications of diabetes. End-stage renal disease (ESRD) from diabetes is the most common single cause of entry to renal replacement programs worldwide. ESRD is devastating to the individual and of enormous financial and social consequences to society. Increasing diabetes prevalence is already being reflected in high diabetic nephropathy prevalence. The early detection and effective management of diabetic nephropathy would delay or prevent the progression of chronic kidney disease. Thus, it is important to understand the exact current status of diabetic nephropathy. We review the epidemiology of diabetic nephropathy including prevalence, incidence, and trends.
Diabetic Nephropathies ; Incidence ; Kidney Failure, Chronic ; Prevalence ; Renal Insufficiency, Chronic

Child ; Humans ; Renal Insufficiency, Chronic ; Kidney Failure, Chronic

Diabetic nephropathy is a common complication of diabetes mellitus and is the leading cause of chronic kidney disease. Glycemic and blood pressure control constitute the main strategies of diabetic nephropathy prevention and treatment. However, despite current therapies, nephropathy progresses to renal failure and end-stage renal disease in many patients. Therefore, new therapeutic strategies targeting different pathophysiological mechanisms are needed. This review article briefly summarizes the standard therapy for diabetic nephropathy and also describes recent advances in potential renoprotective agents that could be used to prevent the development or progression of diabetic nephropathy.
Blood Pressure ; Diabetes Mellitus ; Diabetic Nephropathies* ; Humans ; Kidney Failure, Chronic ; Renal Insufficiency ; Renal Insufficiency, Chronic

Reactive perforating collagenosis (RPC) is one of a range of essential perforating disorders. Two types have been recognized: the childhood or inherited form, and the adult or acquired form. Acquired RPC is usually associated with systemic disease, especially diabetes mellitus and/or renal failure. Lesions of acquired perforating collagenosis are usually smaller than 1 cm, but lesions of the giant variant of acquired perforating collagenosis are larger than 2 cm. We present a case of the giant variant of acquired perforating collagenosis, which has not previously been documented in Korea.
Adult ; Diabetes Mellitus ; Humans ; Kidney Failure, Chronic ; Korea ; Renal Insufficiency

Metastatic calcification is defined as ectopic calcification of soft tissues in patients with a systemic mineral imbalance, and dystrophic calcification or heterotopic ossification is distinct from that disease. The authors encountered a metastatic calcification of the finger in a patient with chronic renal failure, the lesion disappeared spontaneously during the observation period. We report on a case of metastatic calcification of the finger with a review of the literature.
Calcinosis ; Fingers* ; Humans ; Kidney Failure, Chronic* ; Ossification, Heterotopic ; Renal Insufficiency

Child ; Chronic Disease ; Humans ; Kidney Diseases ; Kidney Failure, Chronic ; Renal Insufficiency, Chronic